Health systems individually have struggled to demonstrate improvements to total cost of care because, without data about patients they do not serve, they cannot define a comparison group.
Brian S. Smith
Advertisement
Articles by Brian S. Smith
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Breaking News: CVS Buys Rite Aid, Bartell Drugs
3
Celebrating the Pharmacist’s Impact: How Pharmacists Elevate Care in Every Setting
4
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
5
